Sharck Soup Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Sharck Soup

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sharck who started this subject	5/26/2001 5:22:25 PM
From: besttrader	of 37746

I wonder how much SCIO will gap up tuesday? --> 7:07PM Scios gets closer to drug approval (SCIO) by Nicole Maestri Scios, whose shares were halted throughout Friday trading, said after the closing bell that an FDA advisory committee has unanimously recommended approval of its drug Natrecor to treat acute congestive heart failure. In a release, Scios (SCIO) said that Natrecor would be the first new treatment for acute congestive heart failure in more than 10 years. If it gets final approval, Scios said it will be ready to launch the product at the end of July. Shares were halted at $24.56.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next